Search results
Results from the Tech24 Deals Content Network
WW: July 4, 2024. Genre (s) Action role-playing, hack and slash. Mode (s) Single-player. Zenless Zone Zero [a] is a free-to-play action role-playing game developed and published by miHoYo in mainland China, with global publishing by Cognosphere, d/b/a HoYoverse. The game was released on Windows, iOS, Android and PlayStation 5, on July 4, 2024.
The global subsidiary Cognosphere Pte., Ltd. known as HoYoverse is the co-publisher of Tears of Themis, Genshin Impact, Honkai: Star Rail and Zenless Zone Zero. Etymology [ edit ] The letters "H" and "Y" in MiHoYo's name come from the names of 2 of 3 founders, Cai Haoyu and Luo Yuhao, and the letter "O" was added based on the fact that names of ...
Genshin Impact developer Hoyoverse is working on a new project. On Friday, the studio shared the first trailer for Zenless Zone Zero, an action RPG set in a modern urban setting.Reminiscent of ...
Genshin Impact [a] is an action role-playing game developed by miHoYo, published by miHoYo in mainland China and worldwide by Cognosphere, d/b/a HoYoverse. It was released for Android, iOS, PlayStation 4, and Windows in 2020, and on PlayStation 5 in 2021. The game features an anime -style open-world environment and an action-based battle system ...
HoYoverse. The next game from the makers of Genshin Impact has a release date. Honkai: Star Rail — a turn-based, space-fantasy, tactical RPG — arrives on April 26th. In addition to previously ...
Yu-Peng Chen. Chen Yupeng ( Chinese: 陈宇鹏; pinyin: Chén Yǔpéng; born January 15, 1984), also known by his stage name Chen Zhiyi ( Chinese: 陈致逸; pinyin: Chén Zhìyì ), is a Chinese composer and music producer best known for writing the soundtrack of Genshin Impact, an open-world action role-playing video game by HoYoverse. [3]
Genshin Impact’s long-awaited 3.0 update will launch on August 24th, Hoyoverse announced on Saturday.Dubbed “The Morn a Thousand Roses Brings,” the update will add a new rainforest and ...
Editor's note: The U.S. Food and Drug Administration label for Ozempic states that in placebo-controlled trials of 0.5-1 milligrams of the medication "resulted in a mean increase in heart rate of ...